Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Demetter, P" or (type exact bookEditor and editor="Demetter, P")

Add to list
Belgian guidelines for HER2 testing in gastric cancer

A Jouret-Mourin, Anne Hoorens (UGent) , M Kockx, P Demetter and E Van Cutsem

(2011) BELGIAN JOURNAL OF MEDICAL ONCOLOGY. 5(1). p.14-22
Add to list
- Journal Article
- A1
- open access
Quality of care indicators in rectal cancer

P Demetter, Wim Ceelen (UGent) , E Danse, K Haustermans, A Jouret-Mourin, A Kartheuser, Stéphanie Laurent (UGent) , G Molle, N Nagy, P Scalliet, et al.

(2011) ACTA GASTRO-ENTEROLOGICA BELGICA. 74(3). p.445-450
Add to list
Emphasis on the key role of the pathologist in KRAS mutation testing in the selection of patients for EGFR-targeted therapy in colorectal cancer

Anne Hoorens (UGent) , A Jouret-Mourin, C Sempoux, G De Hertogh and P Demetter

(2010) ACTA GASTRO-ENTEROLOGICA BELGICA. 73(1).
Add to list
Accurate KRAS mutation testing for EGFR-targeted therapy in colorectal cancer : emphasis on the key role and responsibility of pathologists

Anne Hoorens (UGent) , A Jouret-Mourin, C Sempoux, P Demetter, G De Hertogh and E Teugels

(2010) ACTA GASTRO-ENTEROLOGICA BELGICA. 73(4). p.497-503
Add to list
Pathologische beoordeling van het resectiepreparaat bij rectumkanker

Anne Hoorens (UGent) , M De Ridder, A Jouret-Mourin, C Sempoux, Claude Cuvelier (UGent) , N Nagy, G De Hertogh, K Geboes and P Demetter

(2010) NEDERLANDS TIJDSCHRIFT VOOR ONCOLOGIE. 7(4). p.135-145
Add to list
- Journal Article
- A1
Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis

Klaas Vandenbroucke, H de Haard, E Beirnaert, T Dreier, M Lauwereys, Lynn Huyck (UGent) , Jacques Van Huysse (UGent) , P Demetter, L Steidler, Erik Remaut (UGent) , et al.

(2010) MUCOSAL IMMUNOLOGY. 3(1). p.49-56
Add to list
- Conference Paper
- C3
MOLECULAR IMAGING OF TUMOR ASSOCIATED ANGIOGENESIS USING P1227, A NOVEL MRI CONTRAST AGENT TARGETING AVB3 INTEGRIN

ISABELLE DEBERGH (UGent) , Nancy Van Damme (UGent) , Peter Smeets (UGent) , P Demetter, S Carme, Piet Pattyn (UGent) , M Peeters and Wim Ceelen (UGent)

(2009) ANNALS OF ONCOLOGY. 20. p.30-30
Add to list
Pathological assessment of the rectal cancer resection specimen

Anne Hoorens (UGent) , M De Ridder, A Jouret-Mourin, C Sempoux, Claude Cuvelier (UGent) , N Nagy, G De Hertogh, K Geboes and P Demetter

(2009) BELGIAN JOURNAL OF MEDICAL ONCOLOGY. 3(6). p.251-260
Add to list
- Journal Article
- A1
Human Equilibrative Nucleoside Transporter 1 and Human Concentrative Nucleoside Transporter 3 Predict Survival after Adjuvant Gemcitabine Therapy in Resected Pancreatic Adenocarcinoma

R Maréchal, JR Mackey, R Lai, P Demetter, Marc Peeters (UGent) , M Polus, CE Cass, J Young, I Salmon, J Devière, et al.

(2009) Clinical Cancer Research. 15(8). p.2913-2919
Add to list
- Journal Article
- A1
Diagnostic pitfalls in digestive neuroendocrine tumours

I Borbath, F Jamar, T Delaunoit, P Demetter, G Demolin, A Hendlisz, Piet Pattyn (UGent) , Marc Peeters (UGent) , G Roeyen, E Van Cutsem, et al.

(2009) ACTA GASTRO-ENTEROLOGICA BELGICA. 72(1). p.29-33

← Previous

Academic Bibliography

Belgian guidelines for HER2 testing in gastric cancer

Quality of care indicators in rectal cancer

Emphasis on the key role of the pathologist in KRAS mutation testing in the selection of patients for EGFR-targeted therapy in colorectal cancer

Accurate KRAS mutation testing for EGFR-targeted therapy in colorectal cancer : emphasis on the key role and responsibility of pathologists

Pathologische beoordeling van het resectiepreparaat bij rectumkanker

Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis

MOLECULAR IMAGING OF TUMOR ASSOCIATED ANGIOGENESIS USING P1227, A NOVEL MRI CONTRAST AGENT TARGETING AVB3 INTEGRIN

Pathological assessment of the rectal cancer resection specimen

Human Equilibrative Nucleoside Transporter 1 and Human Concentrative Nucleoside Transporter 3 Predict Survival after Adjuvant Gemcitabine Therapy in Resected Pancreatic Adenocarcinoma

Diagnostic pitfalls in digestive neuroendocrine tumours

Contents

Support

Contact